Skip to main content
. Author manuscript; available in PMC: 2023 Apr 26.
Published in final edited form as: J Alzheimers Dis. 2020;75(4):1391–1403. doi: 10.3233/JAD-191265

Table 1.

Demographics of the 28 patients included in the study

Demographic Tolcapone First
(n = 14)
Placebo First
(n = 14)
Total
(n = 28)
Average Age (SD) 62.7 (6.7) 63.6 (9.1) 63.1 (7.8)
Average Age of Onset (SD) 54.2 (3.0) 52.5 (9.0) 53.3 (6.7)
Sex (M/F) 6/8 8/6 14/14
Race (white/other) 13/1 (African American) 12/2 (Asian-Indian) 25/3 (one African American, two Asian-Indian
Average Education Years (SD) 17.4 (1.6) 16.8 (2.0) 17.1 (1.8)
Average MDRS Baseline (SD) 109.2 (23.3) 105.0 (27.1) 107.1 (24.8)
Site (NINDS/Columbia) 4/10 5/9 9/19

SD, standard deviation; M, male; f, female; NINDS, National Institute of Neurological Disorders and Stroke.